Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts

Aptus Pharma Ltd

BSE: 544529 · Pharmaceuticals & Biotechnology · 3 announcements

Share price
₹347.00
Market cap
₹595.1 Cr
Revenue (annual)
₹46.57 Cr
Net profit (annual)
₹4.62 Cr
P/E (TTM)
128.8×Sector 50.4×
Promoter holding
72.89%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 1Earnings Call 1Annual General Meeting 1

Time

All time Last 1 weekLast 1 monthLast 2 monthsLast 3 monthsLast 6 monthsLast 1 year

1 announcement with these filters

19:42 IST BSE
Financial Results

Aptus Pharma H2 FY26 Results: Net Profit ₹2.9 Cr, Up 61.1% YoY

Aptus Pharma Ltd reported revenue from operations of ₹32.2 Cr (+117.6% YoY) and net profit of ₹2.9 Cr (+61.1% YoY) for H2 FY26.

Key figure
Net profit ₹2.9 Cr · +61.1% YoY
Open full results → Read the filing ↗